<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00584597</url>
  </required_header>
  <id_info>
    <org_study_id>TRAUMEEL_S_Krempl</org_study_id>
    <nct_id>NCT00584597</nct_id>
  </id_info>
  <brief_title>A Trial of Homeopathic Medication TRAUMEEL S for the Treatment of Radiation-Induced Mucositis</brief_title>
  <acronym>TRAUMEEL</acronym>
  <official_title>The Safety and Efficacy of the Homeopathic Medication TRAUMEEL S for the Treatment of Radiation-Induced Mucositis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oklahoma</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Oklahoma</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The specific aim of this study will be to determine the safety of TRAUMEEL S for mucositis in
      head and neck cancer patients undergoing radiation therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Oral mucositis is a debilitating side effect of radiation therapy for head and neck cancer
      patients. The severe inflammation of the oral cavity can be detrimental to quality of life
      and cause interruption in vital cancer treatment. Despite numerous proposed therapies, an
      effective agent for oral mucositis has yet to be found. TRAUMEEL S, a homeopathic remedy made
      up of highly diluted botanical extracts and minerals, has shown benefit for mucositis in
      children undergoing chemotherapy. The objective of this study is to evaluate the safety of
      TRAUMMEL S in the prevention and treatment of radiation-induced oral mucositis. The patients
      will use the medication as a mouthwash during radiation therapy and will be evaluated weekly
      with physical examination criteria and questionnaires for symptoms and side effects.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2005</start_date>
  <completion_date type="Actual">October 2010</completion_date>
  <primary_completion_date type="Actual">October 2010</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The specific aim will be to determine the safety of TRAUMEEL S for mucositis in head and neck cancer patients undergoing radiation therapy</measure>
    <time_frame>4 years</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">14</enrollment>
  <condition>Mucositis</condition>
  <condition>Head and Neck Cancer</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Saline</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Traumeel S 1 mL</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Traumeel S 2 mL</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Traumeel S 3 mL</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>Saline Control</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Traumeel S</intervention_name>
    <description>Traumeel S 1 mL</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Traumeel S</intervention_name>
    <description>Traumeel S 2mL</description>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Traumeel S</intervention_name>
    <description>Traumeel S 3mL</description>
    <arm_group_label>4</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Head and neck cancer patients post resection of primary tumor with negative or
             microscopically positive surgical margins

          -  Patients undergoing planned radiation therapy

          -  Age 18 to 99

          -  Nonsmokers

        Exclusion Criteria:

          -  Head and neck cancer patients post resection of primary tumor with grossly positive
             surgical margins

          -  Patients receiving adjuvant chemotherapy

          -  Pediatric patients (age &lt; 18)

          -  Pregnant women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Greg Krempl, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Oklahoma</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Oklahoma Health Sciences Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 20, 2007</study_first_submitted>
  <study_first_submitted_qc>December 31, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 2, 2008</study_first_posted>
  <last_update_submitted>December 10, 2010</last_update_submitted>
  <last_update_submitted_qc>December 10, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 13, 2010</last_update_posted>
  <responsible_party>
    <name_title>Greg Krempl, MD</name_title>
    <organization>University of Oklahoma Health Sciences Center</organization>
  </responsible_party>
  <keyword>Radiation-Induced Mucositis</keyword>
  <keyword>Head and neck cancer</keyword>
  <keyword>TRAUMEEL</keyword>
  <keyword>Mucositis</keyword>
  <keyword>Radiation</keyword>
  <keyword>Oral cancer</keyword>
  <keyword>Inflammation of the mouth</keyword>
  <keyword>Homeopathic Medication</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Head and Neck Neoplasms</mesh_term>
    <mesh_term>Mucositis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

